tau protein drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Amyloid-beta | interacts_with | tau protein | — | 1 |
| tau protein | associated_with | Alzheimer's disease | — | 1 |
| tau protein | biomarker_for | Alzheimer's disease | — | 2 |
| tau protein | risk_factor_for | neuronal loss | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Epigenetics in Alzheimer's Disease. (2022)
- Cerebrospinal fluid and the early brain development of autism. (2018)
- Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells. (2016)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. (2014)
- Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner. (2012)
- Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study. (2012)
- Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. (2011)
- The role of DYRK1A in neurodegenerative diseases. (2011)
- Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tau protein | drug | 9 | 12 |